Clinical significance of immunogenicity in biologic therapy
Actas Dermosifiliogr. 2014 Jan-Feb;105(1):1-4.
doi: 10.1016/j.ad.2013.07.002.
Epub 2013 Sep 14.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España. Electronic address: rriveradiaz@hotmail.com.
- 2 Servicio de Dermatología. Hospital Universitario La Paz, Madrid, España.
- 3 Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España.
No abstract available
MeSH terms
-
Algorithms
-
Antibodies, Anti-Idiotypic / biosynthesis
-
Antibodies, Anti-Idiotypic / blood
-
Antibodies, Anti-Idiotypic / immunology
-
Antibody Formation / drug effects
-
Biological Therapy*
-
Drug Resistance / drug effects
-
Drug Resistance / immunology
-
Drug Substitution
-
Enzyme-Linked Immunosorbent Assay
-
Humans
-
Immunologic Factors / blood
-
Immunologic Factors / immunology*
-
Immunologic Factors / pharmacology
-
Immunologic Factors / therapeutic use
-
Immunosuppressive Agents / therapeutic use
-
Interleukins / antagonists & inhibitors
-
Treatment Failure
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Antibodies, Anti-Idiotypic
-
Immunologic Factors
-
Immunosuppressive Agents
-
Interleukins
-
Tumor Necrosis Factor-alpha